Delivery Order SPE2DB20D1004-SPE2DB24FG5K1
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,275.33, and has an ultimate completion date of August 1, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is not set aside and is part of a...
This federal contract award is for the delivery of MESALAMINE 800 MG DR TABLET 180S to the Defense Logistics Agency (DLA). The $11,379.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Mesalamine DR 400 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,652.02 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of September 17, 2024. This contract is not set aside for any specific business category. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,518.52 Firm Fixed Price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a performance period through May 7, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of MESALAMINE ER 0.375 GRAM CAP 120S. The order, valued at $6,348.20, has an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp. for the supply of Mesalamine ER 0.375 gram capsules. The contract has a ceiling value of $10,911.93 and an ultimate completion date of September 10, 2024. It is a firm-fixed-price contract type. The award is not associated with a set-aside program. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the provision of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a firm fixed price of $2,195.35 and a completion date of May 17, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is providing this medication under a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has a ceiling value of $7,881.82 and a period of performance through May 31, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,020.34 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,238.51 firm fixed-price delivery order contract is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...